Dutasteride
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1355 publications
Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS).
Journal: The aging male : the official journal of the International Society for the Study of the Aging Male
Published: March 24, 2026
Persistent Alopecic Patches Following Dutasteride Mesotherapy for Female Androgenetic Alopecia: A Case Series.
Journal: Journal of drugs in dermatology : JDD
Published: March 04, 2026
Depression risk of 5-alpha reductase inhibitors: impact of active-comparator versus non-drug user control groups on risk measurement.
Journal: Postgraduate medicine
Published: February 23, 2026
Characterization and Management of Androgenetic Alopecia in Transgender and Gender-Diverse Individuals: A Narrative Review.
Journal: Dermatology and therapy
Published: February 16, 2026
Successful Hair Regrowth in Early Frontal Fibrosing Alopecia With Combination Therapy.
Journal: Cureus
Published: February 12, 2026
Combined therapy with dutasteride and tadalafil vs dutasteride or tadalafil monotherapy in benign prostatic hyperplasia: a randomised phase III trial.
Journal: BJU international
Published: February 10, 2026
Injectable Therapy for Androgenetic Alopecia: A Systematic Review.
Journal: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
Published: January 28, 2026
Oral finasteride use and sexual adverse events: signal detection from disproportionality analyses of data from the United States Food and Drug Administration Adverse Event Reporting System.
Journal: The Journal of dermatological treatment
Published: January 12, 2026
The role of 5-alpha reductase inhibitors in transurethral resection of the prostate: a meta-analysis of randomised controlled trials.
Journal: BJU international
Published: January 08, 2026
Scalp Microinfusion with Dutasteride Using the MMP® Technique for Male Androgenetic Alopecia: A 12-Month Real-World Observational Case Series.
Journal: Skin appendage disorders
Published: December 29, 2025
The use of oral dutasteride, minoxidil, and finasteride for treating endocrine therapy-induced hair loss from breast cancer treatment: A case series study.
Journal: JAAD case reports
Published: December 26, 2025
Drug-induced male infertility: a real-world study using FAERS and EudraVigilance databases.
Journal: Frontiers in pharmacology
Published: December 13, 2025
Last Updated: 04/28/2026